Joshua Ooi

Has grant

Lab Head

Monash University Malaysia.

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Immunology Immunology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joshua Ooi is a Lab Head at Monash University, Australia. His research focuses on autoimmune diseases and immunology, with recent articles addressing topics such as T regulatory cells, ANCA-associated vasculitis, and the role of innate immunity. Ooi is actively involved in exploring therapeutic strategies for conditions such as lupus nephritis and COVID-19.

Recent Grants

Grant: Close

Targeted regulatory T cells (Tregs) to treat lupus nephritis

Open Date: 2021-12-01

Close Date: 2023-11-30

Grant: Close

Genetically engineering regulatory T cells to treat SLE

Open Date: 2018-09-01

Close Date: 2021-08-31

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Julie Monk

AUSTRALIA

View details

Edward Giles

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua Ooi

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti–glomerular basement membrane disease antigen

Smith-specific regulatory T cells halt the progression of lupus nephritis

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

Editorial: Innate immunity in vasculitis

Epithelially Restricted Interferon Epsilon Protects Against Colitis

Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study

The Influence of Cross-Reactive T Cells in COVID-19

Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy

Development of a radiomics nomogram to predict the treatment resistance of Chinese MPO-AAV patients with lung involvement: a two-center study

NETosis as an oncologic therapeutic target: a mini review

Collaborators (2)

Julie Monk

Edward Giles

Make your next move.